Viatris Inc.

AI Score

0

Unlock

11.71
-0.09 (-0.76%)
At close: Jan 14, 2025, 3:59 PM
11.62
-0.75%
After-hours Jan 14, 2025, 05:39 PM EST
undefined%
Bid 11.62
Market Cap 13.98B
Revenue (ttm) -
Net Income (ttm) -
EPS (ttm) -0.73
PE Ratio (ttm) -16.04
Forward PE n/a
Analyst Hold
Ask 11.85
Volume 6,831,214
Avg. Volume (20D) 7,947,809
Open 11.85
Previous Close 11.80
Day's Range 11.65 - 12.02
52-Week Range 9.93 - 13.62
Beta undefined

About VTRS

Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, including noncommunicable and infectious diseases; biosimilars in the areas of oncology, immunology, end...

Sector Healthcare
IPO Date Mar 17, 1980
Employees 32,000
Stock Exchange NASDAQ
Ticker Symbol VTRS

Analyst Forecast

According to 3 analyst ratings, the average rating for VTRS stock is "Hold." The 12-month stock price forecast is $14, which is an increase of 19.56% from the latest price.

Buy 33.33%
Hold 33.33%
Sell 33.33%
Stock Forecasts

Next Earnings Release

Viatris Inc. is scheduled to release its earnings on Feb 26, 2025, before market opens.
Analysts project revenue of $3.62B, reflecting a -5.38% YoY shrinking and earnings per share of 0.58, making a -6.45% decrease YoY.
2 months ago · Source
+13.52%
Viatris shares are trading higher after the compan... Unlock content with Pro Subscription
5 months ago · Source
+6.51%
Viatris shares are trading higher after the company reported better-than-expected Q2 financial results.